New AI-Enabled 3D Mapping with C-Arm System May Improve Efficiency and Outcomes of Endovascular Procedures

Article

Emerging technology could provide key advances in pre-op planning and intraoperative management in endovascular surgery.

The addition of new 3D imaging capabilities to a mobile C-arm system may enhance procedure planning, improve real-time intraoperative guidance, and significantly reduce procedure times for endovascular surgery procedures.

Endovascular surgeons who use the Zenition image-guided therapy mobile C-arm system (Philips) will now have advanced 3D image guidance capabilities thanks to a new partnership agreement between Philips and the United Kingdom-based company Cydar, which specializes in cloud-based procedure map software.

Philips says combining the Zenition system’s versatility and innovative image capture with the artificial-intelligence (AI)-enabled technology and patient-specific 3D mapping of target vasculature offered with Cydar EV Maps may lead to greater efficiency, safety, and improved outcomes. Not only does the technology bolster procedure planning, Philips notes the real-time updates of the 3D mapping can provide enhanced guidance for addressing findings encountered during endovascular procedures.

The integration of these technologies could lead to a 50 percent reduction in radiation exposure and a greater than 20 percent reduction in procedure times, according to Philips.

“With Philips’ integrated portfolio, using validated AI and cloud technologies, we can facilitate collaborative care to optimize surgical pathways,” said Karim Boussebaa, the General Manager of Image Guided Therapy Systems at Philips. “Philips has a strong global network of mobile surgery systems and recognizes that Cydar’s EV Maps solution can play a key role in further improving our integrated offering for endovascular procedures.”

Recent Videos
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Related Content
© 2025 MJH Life Sciences

All rights reserved.